BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37129682)

  • 1. A simple nomogram for predicting occult lymph node metastasis of non-small cell lung cancer from preoperative computed tomography findings, including the volume-doubling time.
    Karita R; Suzuki H; Onozato Y; Kaiho T; Inage T; Ito T; Tanaka K; Sakairi Y; Yoshino I
    Surg Today; 2024 Jan; 54(1):31-40. PubMed ID: 37129682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram based on prognostic nutrition index and Chest CT imaging signs predicts lymph node metastasis in NSCLC patients.
    Chen M; Yang Y; He C; Chen L; Cheng J
    J Xray Sci Technol; 2022; 30(3):599-612. PubMed ID: 35311733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of solid-part tumour volume doubling time in patients with radiological part-solid or solid lung cancer.
    Setojima Y; Shimada Y; Tanaka T; Shigefuku S; Makino Y; Maehara S; Hagiwara M; Masuno R; Yamada T; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2020 Apr; 57(4):763-770. PubMed ID: 31746987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting occult lymph node metastasis by nomogram in patients with lung adenocarcinoma ≤2 cm.
    Wang Z; Wu Y; Wang L; Gong L; Han C; Liang N; Li S
    Future Oncol; 2021 Jun; 17(16):2005-2013. PubMed ID: 33784826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth characteristics of early-stage (IA) lung adenocarcinoma and its value in predicting lymph node metastasis.
    Liu M; Mu J; Song F; Liu X; Jing W; Lv F
    Cancer Imaging; 2023 Dec; 23(1):115. PubMed ID: 38041175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Kaseda K; Asakura K; Kazama A; Ozawa Y
    World J Surg; 2016 Dec; 40(12):2976-2983. PubMed ID: 27456499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel nomogram to predict lymph node metastasis in cT1 non-small-cell lung cancer based on PET/CT and peripheral blood cell parameters.
    Wei B; Jin X; Lu G; Zhao T; Xue H; Zhang Y
    BMC Pulm Med; 2023 Jan; 23(1):44. PubMed ID: 36717907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of lymph node metastasis of clinical stage IA non-small cell lung cancer based on the tumor volume doubling time.
    Nakahashi K; Shiono S; Nakatsuka M; Endo M
    Surg Today; 2022 Jul; 52(7):1063-1071. PubMed ID: 35044521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.
    Shi YM; Niu R; Shao XL; Zhang FF; Shao XN; Wang JF; Wang XS; Liu B; Yu WJ; Wang YT
    Nucl Med Commun; 2020 May; 41(5):459-468. PubMed ID: 32187163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
    Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
    Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
    Park SY; Yoon JK; Park KJ; Lee SJ
    Cancer Imaging; 2015 Dec; 15():21. PubMed ID: 26694918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram to Predict Occult N2 Lymph Nodes Metastases in Patients With Squamous Nonsmall Cell Lung Cancer.
    Jiang L; Jiang S; Lin Y; Yang H; Xie Z; Lin Y; Long H
    Medicine (Baltimore); 2015 Nov; 94(46):e2054. PubMed ID: 26579815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative risk factors of lymph node metastasis in clinical N0 lung adenocarcinoma of 3 cm or less in diameter.
    Fang C; Xiang Y; Han W
    BMC Surg; 2022 Apr; 22(1):153. PubMed ID: 35488235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
    Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
    Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.
    Das SK; Fang KW; Xu L; Li B; Zhang X; Yang HF
    Sci Rep; 2021 May; 11(1):10829. PubMed ID: 34031529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor.
    Cho JY; Leem CS; Kim Y; Kim ES; Lee SH; Lee YJ; Park JS; Cho YJ; Lee JH; Lee CT; Yoon HI
    BMC Pulm Med; 2018 Sep; 18(1):151. PubMed ID: 30200917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.